BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 27242185)

  • 21. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
    Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499.
    Byun SY; Shin YJ; Nam KY; Hong SP; Ahn SK
    Life Sci; 2015 Jan; 120():1-7. PubMed ID: 25447448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11beta-hydroxysteroid dehydrogenase type 1.
    Berthiaume M; Laplante M; Festuccia W; Gélinas Y; Poulin S; Lalonde J; Joanisse DR; Thieringer R; Deshaies Y
    Endocrinology; 2007 May; 148(5):2391-7. PubMed ID: 17272400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emodin, a natural product, selectively inhibits 11beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice.
    Feng Y; Huang SL; Dou W; Zhang S; Chen JH; Shen Y; Shen JH; Leng Y
    Br J Pharmacol; 2010 Sep; 161(1):113-26. PubMed ID: 20718744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors still improve metabolic phenotype in male 11β-HSD1 knockout mice suggesting off-target mechanisms.
    Harno E; Cottrell EC; Yu A; DeSchoolmeester J; Gutierrez PM; Denn M; Swales JG; Goldberg FW; Bohlooly-Y M; Andersén H; Wild MJ; Turnbull AV; Leighton B; White A
    Endocrinology; 2013 Dec; 154(12):4580-93. PubMed ID: 24169553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific reduction of G6PT may contribute to downregulation of hepatic 11β-HSD1 in diabetic mice.
    Du H; Liu L; Wang Y; Nakagawa Y; Lyzlov A; Lutfy K; Friedman TC; Peng X; Liu Y
    J Mol Endocrinol; 2013 Apr; 50(2):167-78. PubMed ID: 23267038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time of the day for 11beta-HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice.
    Véniant MM; Hale C; Komorowski R; Chen MM; St Jean DJ; Fotsch C; Wang M
    Diabetes Obes Metab; 2009 Feb; 11(2):109-17. PubMed ID: 18479468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains.
    Alberts P; Nilsson C; Selen G; Engblom LO; Edling NH; Norling S; Klingström G; Larsson C; Forsgren M; Ashkzari M; Nilsson CE; Fiedler M; Bergqvist E; Ohman B; Björkstrand E; Abrahmsen LB
    Endocrinology; 2003 Nov; 144(11):4755-62. PubMed ID: 12960099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caulerpa lentillifera extract ameliorates insulin resistance and regulates glucose metabolism in C57BL/KsJ-db/db mice via PI3K/AKT signaling pathway in myocytes.
    Sharma BR; Kim HJ; Rhyu DY
    J Transl Med; 2015 Feb; 13():62. PubMed ID: 25889508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 11β-HSD1 reduces metabolic efficacy and adiponectin synthesis in hypertrophic adipocytes.
    Koh EH; Kim AR; Kim H; Kim JH; Park HS; Ko MS; Kim MO; Kim HJ; Kim BJ; Yoo HJ; Kim SJ; Oh JS; Woo CY; Jang JE; Leem J; Cho MH; Lee KU
    J Endocrinol; 2015 Jun; 225(3):147-58. PubMed ID: 25869616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, INU-101.
    Hong SP; Han D; Chang KH; Ahn SK
    Eur J Pharmacol; 2018 Sep; 835():169-178. PubMed ID: 30096297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidiabetic effects of 11beta-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis.
    Lloyd DJ; Helmering J; Cordover D; Bowsman M; Chen M; Hale C; Fordstrom P; Zhou M; Wang M; Kaufman SA; Véniant MM
    Diabetes Obes Metab; 2009 Jul; 11(7):688-99. PubMed ID: 19527482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue.
    Mai K; Andres J; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):419-25. PubMed ID: 17555498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a novel 11β-HSD1 inhibitor from a high-throughput screen of natural product extracts.
    Park SB; Park JS; Jung WH; Park A; Jo SR; Kim HY; Dal Rhee S; Ryu SY; Jeong HG; Park S; Lee H; Kim KY
    Pharmacol Res; 2015 Dec; 102():245-53. PubMed ID: 26515507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genistein inhibits glucocorticoid amplification in adipose tissue by suppression of 11β-hydroxysteroid dehydrogenase type 1.
    Tagawa N; Kubota S; Kobayashi Y; Kato I
    Steroids; 2015 Jan; 93():77-86. PubMed ID: 25447798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
    Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
    Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of hepatic 11β-hydroxysteroid dehydrogenase-1 expression in calcium-deficient rats.
    Takaya J; Iharada A; Okihana H; Kaneko K
    Ann Nutr Metab; 2011; 59(2-4):73-8. PubMed ID: 22142627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute anti-obesity effects of intracerebroventricular 11β-HSD1 inhibitor administration in diet-induced obese mice.
    Seo M; Islam SA; Moon SS
    J Neuroendocrinol; 2018 Mar; 30(3):e12580. PubMed ID: 29418022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
    Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
    Baudrand R; Domínguez JM; Carvajal CA; Riquelme A; Campino C; Macchiavello S; Bozinovic M; Morales M; Pizarro M; Solis N; Escalona A; Boza C; Arrese M; Fardella CE
    Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.